Similar to the in vitro results, treatment with panitumumab resulted in an inhibition of ligand-induced pEGFR in A431 established tumor xenograft tissue as detected by immunoprecipitation and immunoblotting with anti-pTYR and anti-EGFR antibodies (Figure 1B). This evidence concerns the gene EGFR and neoplasm.